Satellite Bio
Signal active
Organization
Contact Information
Overview
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
About
Industries
Biotechnology, Medical, Biopharma
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Satellite Bio headquartered in United States, North America, operates in the Biotechnology, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $2.4B in funding across 24 round(s). With a team of 11-50 employees, Satellite Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Satellite Bio, raised $19.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
3
Lead Investors
0
Total Funding Amount
$101.5M
Details
2
Satellite Bio has raised a total of $101.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 82.5M | ||
| 2020 | Seed | 19.0M |
Investors
Satellite Bio is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Satellite Bio | - | FUNDING ROUND - Satellite Bio | 19.0M |
| Lightspeed Venture Partners | - | FUNDING ROUND - Lightspeed Venture Partners | 19.0M |
| Satellite Bio | - | FUNDING ROUND - Satellite Bio | 19.0M |
| Polaris Partners | - | FUNDING ROUND - Polaris Partners | 19.0M |
Recent Activity
There is no recent news or activity for this profile.